Prior to this role, Dr. Bernstein led pharmaceutical and advocacy practices for two and a half years as the senior vice president of pharmacy practice and government affairs at APhA, according to a June 2 press release. For more than 30 years, Dr. Bernstein has worked on advocacy and regulation efforts in senior leadership positions for the FDA and Pfizer.
“I am excited to be selected to serve as APhA’s Interim CEO, an organization that I’ve cherished and actively been involved with since my student pharmacist days,” Dr. Bernstein said.
As interim CEO, Dr. Bernstein will help steer the APhA board in its national search for a CEO.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
